Search - tctmd.com

Displaying 101 - 120 of 287

Sort: Relevancy | Date

$Intranasal Diuretic for the Treatment of CHF Refractor.$

Presentation THT 2023

Intranasal Diuretic for the Treatment of CHF Refractory to Oral Diuretics. Have Completed our IND Opening Study Which Demonstrated Similar Bioavailability vs Oral and IV Formulations. Our Product Is Intended to Act as an Outpatient Option for Patients…

Presenter: Ben Esque

March 21, 2023

Reprieve: Intelligent Diuretic Management Strategies

Presentation THT 2023

Reprieve: Intelligent Diuretic Management Strategies

Presenter: Jeffrey Testani

March 20, 2023

Medical Therapies of DHF and the Concept of "Diuretic Resistance"

Presentation THT 2023

Medical Therapies of DHF and the Concept of "Diuretic Resistance"

Presenter: W. H. Wilson Tang

March 20, 2023

Invasive Investigational Device IDE Studies: For Diuretic-Resistant Patients Only?

Presentation THT 2023

Invasive Investigational Device IDE Studies: For Diuretic-Resistant Patients Only?

Presenter: Ulrich Jorde

March 20, 2023

How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA

News Conference News ACC 2023

How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA

March 09, 2023

HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension

News Conference News ACC 2023

HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension

March 08, 2023

TRILUMINATE Pivotal: TEER With the TriClip Benefits Patients With Severe TR

News Conference News ACC 2023

TRILUMINATE Pivotal: TEER With the TriClip Benefits Patients With Severe TR

March 04, 2023

European Societies Define Best Practices for Performing Renal Denervation

News Daily News

European Societies Define Best Practices for Performing Renal Denervation

February 21, 2023

February 2023 News Roundup

News Opinion CV Team Dispatch

February 2023 News Roundup

February 15, 2023

Top General Cardiology and Prevention News of 2022

News Daily News

Top General Cardiology and Prevention News of 2022

Michael O'Riordan

December 26, 2022

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

News Daily News

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

December 09, 2022

TCTMD’s Top 10 Most Popular Stories for November 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

December 01, 2022

Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms

News Daily News

Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms

November 23, 2022

Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results

News Daily News

Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results

November 16, 2022

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

News Conference News AHA 2022

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Michael O'Riordan

November 09, 2022

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

News Conference News AHA 2022

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Michael O'Riordan

November 07, 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

News Conference News AHA 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

November 05, 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

News Conference News AHA 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

November 05, 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

September 16, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.